INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2020-02-12 146455cbm92暂无昵称

这个杂志19年十月刚升到二区top，20年1月又降为三区。

142 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2023-03-09 ms3000001011350398 来自上海

偏重的研究方向：分子生物学
经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗

0 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2021-03-28 ms1000000382906414

审稿速度:1.0
经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。

101 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2021-04-06 HHPZY

审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0
偏重的研究方向：类风湿关节炎
经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天

88 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2021-01-18 **爱豆

审稿审了一个月了，还没反应，最近速度不快啊

148 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2020-05-08 qiuwm1984

审稿速度:1.0 | 投稿命中率:75.0
经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。

212 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2020-03-27 146e00b0m22(暂无昵称)

是要把所有图片的原始数据上传吗，还是只是WB

176 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2022-11-04 ms8000000438373883

收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome.

60 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2023-02-11 予薏来自广东省

哭了，2月7号投出，4天pending review后今天模板被拒

49 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=584603, encodeId=d36f584603b8, content=这个杂志19年十月刚升到二区top，20年1月又降为三区。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/54085c4235d7defba845ede8aae17608.jpg, createdBy=11985125580, createdName=146455cbm92暂无昵称, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=951897, encodeId=0ac995189eec, content=审稿速度:1.0 经验分享：21年3月9号投稿 15号送审 25号出来一审意见，给了3天时间小修，27号上午修回去，目前状态等待编辑决定。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210329/5f7ca616e44d449e9a442316aae137a4/092ff4d0c403463abac692597f712838.jpg, createdBy=91da5471584, createdName=ms1000000382906414, createdTime=Sun Mar 28 17:58:46 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954193, encodeId=7195954193f2, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2000.0 偏重的研究方向：类风湿关节炎 经验分享：真的非常快了毕业首选，3.4投出，3月15一审回来给了五天小修，老板比较谨慎，又申请延了3天，23号修回，当天晚上就接收了，之后校稿也很快，28号就发表了，从投稿到接收正好20天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=181e5477323, createdName=HHPZY, createdTime=Tue Apr 06 13:29:34 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917623, encodeId=000691e62346, content=审稿审了一个月了，还没反应，最近速度不快啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200805/fe2680c295f74c7a8e5319e11dbb8b39/afe0205d68974149ad3f5085f9b6408a.jpg, createdBy=80972258745, createdName=**爱豆, createdTime=Mon Jan 18 03:38:04 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590443, encodeId=03755904436a, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：研究水平一般，但数据相对完整、严谨，投稿后2周左右给审稿意见，2个审稿人，1个正面，1个小修。前后20多天接受，期间对图片、论文细节作了许多修改。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=177c21936, createdName=qiuwm1984, createdTime=Fri May 08 10:27:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587547, encodeId=9b0c58e547a8, content=是要把所有图片的原始数据上传吗，还是只是WB, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Fri Mar 27 00:00:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098507, encodeId=f6c3209850e7c, content=收到专刊邀稿，不知真假 We contacted you on 03rd of October, regarding a Special Issue entitled "Roles and Function of Extracellular Vesicles in Diseases", to be published in the International Journal of Molecular Sciences (ISSN 1422-0067, IF 6.208). Dr. Won Jong Rhee is serving as Guest Editor for this issue. Based on your expertise in this field, we think you could make an excellent contribution. The Special Issue will focus on (1) biogenesis or biochemical properties of EVs, (2) functions of EVs, (3) engineering EVs for therapeutic development, (4) development of novel EV sources, and (5) EV-based applications in therapy and diagnosis. Experimental papers, up-to-date review articles, and commentaries are all welcome., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e3a6513284, createdName=ms8000000438373883, createdTime=Fri Nov 04 15:57:27 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114144, encodeId=79ab2114144e0, content=哭了，2月7号投出，4天pending review后今天模板被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d615588471, createdName=予薏, createdTime=Sat Feb 11 18:56:34 CST 2023, time=2023-02-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2100383, encodeId=dada2100383aa, content=pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8c05109762, createdName=14610e06m71(暂无昵称), createdTime=Mon Nov 14 09:32:59 CST 2022, time=2022-11-14, status=1, ipAttribution=)]

2022-11-14 14610e06m71(暂无昵称)

pending review的第三天了，是要挂了吗？ 11号投的，谁来安慰我一下

34 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务